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Background: The porcine circovirus-associated disease (PCVAD) has been known since 1991 in Canada, but the first
outbreak of PCVAD in Colombia was reported in 2007. In order to understand the molecular epidemiology of the
disease and to establish the origin of the virus in the country, the study presented here intended to evaluate the
presence of PCV2-associated systemic infection in piglets from different geographical regions over a period of
9-years (2002 -2010). The analysis included samples collected before, during and after outbreaks of PCVAD in pigs
from Colombia. The PCV2 ORF2 from the positive samples was sequenced and used to determine the genotypes of
the strains and to study the dynamic of these genotypes throughout the time.
Results: PCV2 DNA was detected in cases related to PCV2-associated systemic infection as well as in healthy pigs
with a presumable persistent infection. The analysis of the ORF2 nucleotide full length sequence of twenty-three
strains allowed to divide them into two groups: PCV2a and PCV2b. At the amino acid level the main variations in
the sequence of the capsid protein were found in regions located within the immunoreactive areas.
Conclusions: The results of this study demonstrated for the first time, that the two subgroups: PCV2a and PCV2b
have been circulating in swine from Colombia. In addition, the study showed that genotype PCV2b is present in
Colombian pigs suffering from both clinical and presumable persistent infection and that the PCV2b genotype was
present in the Colombian pig population even before recognition of the disease in the country and it became
predominant through time.
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Porcine circovirus type 2 (PCV2), a member of the
Circoviridae family, is a small non-enveloped virus, con-
taining a single-stranded circular deoxyribonucleic acid
(DNA) genome [1], it is distributed worldwide and is con-
sidered to be an important emerging pathogen associated
with several different syndromes and diseases in pigs, col-
lectively grouped as porcine circovirus diseases (PCVD)
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article, unless otherwise stated.a multifactorial disease, considered one of the most eco-
nomically important swine diseases worldwide [3]. PCV2-
associated systemic infection is clinically characterized by
wasting, dyspnea, and lymphadenopathy and might be as-
sociated with diarrhea, pallor, and jaundice [4]. The most
relevant histological lesions in this condition occur in
lymphoid organs and consist of extensive lymphocytic de-
pletion, macrophage infiltration, a few multinucleated
giant cells, and botryoid basophilic cytoplasmic inclusion
bodies [5].
PCV2 DNA genome is about 1767–1768 nucleotides
long [6] and encodes for three open reading frames
(ORFs) [7]. The ORF1 encodes the replication-relatedCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Figure 1 Agarose gel showing the products of conventional
PCR amplification of PCV2 from serum samples. MP: molecular
weight standards (100 bp ladder). Lane 1 – 9 are field positive
samples; lane 10: positive control.
Table 1 PCV2 DNA detection in serum samples and tissue
samples collected during 2002-2007
Year Conventional PCR








13/22 (59.1%) 21/110 (19.1%) 11/11 (100%)
*Positive farms/total examined.
**Positive samples/total examined.
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sult of Rep-transcript alternative splicing process [8,9].
The ORF2 encodes the capsid protein, the only structural
viral protein that is also the most variable nucleotide se-
quence of the viral genome [10,11]. Finally, the ORF3 em-
bedded within ORF1, encodes a protein that is not
essential for viral replication but is fundamental to the de-
velopment of the viral pathogenesis [12,13].
PCV2 is classified into two main genotypes, PCV2a
and PCV2b which were further subdivided into different
clusters, 1A–1C and 2A–2E for PCV2b and PCV2a, re-
spectively [11]. A third genotype, PCV2c, has only been
found in Denmark [14]. A new type of PCV referred to
as PCV1/2a was reported in Canada in 2009, it was
found to be a chimeric virus containing ORF1 of PCV1
and ORF2 of PCV2a [15]. Recently, two additional geno-
types PCV2d and PCV2e, were described following se-
quence analysis of PCV2 isolates from China [16].
However, a subsequent analysis of data sequences failed
to support the new genotypes reported [17].
In South America, PCV2 has been circulating in Brazil
since 1988 [18], but it was also detected in Argentina
[19,20], and Chile [21]. PCV2-associated systemic infec-
tion was first reported in 2007 [22] in Colombia from
pig farms located in different regions. In spite of that,
genetic information about PCV2 strains in pig herds
from the country had been unavailable until now. The
main purpose of this work was to establish molecular
detection and to achieve genetic and phylogenetic com-
parisons of full-length sequences of the ORF2 from
PCV2 strains recovered from clinically healthy and
PCV2-associated systemic infection affected pigs from
different production systems in Colombia. Another pur-
pose was to study the viral genotypes dynamics through
time to trace temporal changes, in order to understand
the molecular epidemiology of PCV2 in Colombia.
Results
PCV2 DNA detection
The results of the amplification of the PCV2 in serum
samples tested by conventional PCR are illustrated in
Figure 1. A total of 21 out of 110 whole serum samples
(19.1%) collected during 2002 - 2005 were positive to
PCV2. Those samples were from 13 farms located in
Cundinamarca (6), Risaralda (4) and Valle (3). The two
oldest positive samples detected in farms from Valle and
Risaralda were from 2002 (Table 1). Additionally, PCV2
DNA was identified in 11 archived necropsy samples
collected during PCVAD outbreaks that occurred in
Colombia during 2006-2007. On the other hand, from
the samples collected over the period of 2009 – 2010,
PCV2 DNA was identified in 34 serum samples (25.2%)
from 14 farms (51.8%) and in 40 tissue samples (80%)
from 50 pigs that showed clinical signs compatible withPCV2-associated systemic infection (Table 2). It is im-
portant to mention that PCV2 antigen was demon-
strated previously by IHC in the lymph nodes of these
40 PCR positive samples. Detection was also associated
with histological changes suggestive of PCV2-associated
systemic infection (granulomatous inflammation and
lymphoid depletion) [23].
PCV2 PCR specificity and sensitivity
There was no amplification with the designed primers
for PCV2 ORF2 for any of the four bacterial or the five
viral nucleic acids from swine pathogens used to test the
specificity of the PCR under the conditions used in this
study. The conventional PCR test detected PCV-2 DNA
up to a dilution of 10−3, corresponding to 2.2 × 103
TCID50/ml.
Genetic characterization
The complete genome of 23 Colombian ORF2 PCV2
sequences showed a length of 702 bp and revealed a
Figure 2 Phylogenetic tree constructed by the neighbor-joining method based on the complete 702-nt sequence of the PCV2 ORF2.
PCV2 Colombian strains evaluated in this study are shown underlined. Sixty eight strains whose entire or partial sequences have been
reported were included for comparison. PCV1 isolate FJ475129 was included as outgroup.
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Table 2 PCV2 DNA detection in serum samples and cases
collected during 2009-2010
Conventional PCR
Serum samples Tissue samples
Geopraphic
origin
Positive* Positive** Positive* Positive**
Farms serum Farms tissue
Antioquia 7/10 20/50 6/6 15/15
Cundinamarca 2/7 4/35 6/6 12/21
Risaralda 3/5 3/25 1/2 3/4
Valle 2/5 7/25 4/4 10/10
14/27 34/135 17/18 40/50
*Positive farms/total examined.
**Positive samples/total examined.
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nucleotide level, the PCV2a and PCV2b sequences
shared between them an identity of 98% -100% and
98.8 -100% respectively. The two genotypes of the PCV2
were found both in the strains isolated from PCV2-
associated systemic infection affected animals and in
those from healthy pigs belonging to the main pig-
producing provinces of Colombia. The sequence analysis
showed that PCV2b is the predominant genotype in
Colombia (Figure 2). Interestingly, in two farms (farms 2
and 7), both genotypes, PCV2a and PCV2b, were de-
tected before the first outbreak and they were also dis-
cerned during and after outbreaks of PCVAD in
Colombia (Table 3).
The PCV2b Group included 19 strains that contained
the signature motif CCCCGC encoding proline (P) and
arginine (R) at nucleotides 262–267 and amino acids
88–89. Fifteen nucleotide substitutions that originated
five amino acid substitutions: I57V, R63K, A190T, L226F
and D228A were observed in the ORF2 from the PCV2b
Colombian strains. On the other hand, the PCV2a
Group consisted of four strains with the nucleotide se-
quence AAAATC encoding lysine (K) and isoleucine (I).
Sixteen nucleotide substitutions were observed in the
ORF2 from the PCV2a Colombian isolates, which led to
twelve amino acid substitutions: T47A, R59A, T63R,
K75N, L76I, T134N, L136Q, L183I, L187I, K206I and
N232K. In this study the main positions of amino acid
replacements among Colombian ORF2 PCV2 sequences
were located at amino acid positions 57-89, 121–134
and 190-210 (Figure 3).
Phylogenetic analyses
The phylogenetic analysis of the 23 ORF2 PCV2 se-
quences from this study along with 68 sequences pub-
lished in the GenBank database that are representative
of all PCV2 genotypes is shown in Figure 2. The phylo-
genetic tree reproduces all the PCV2 clusters previouslydescribed [11]. The 23 strains were divided into the two
genotypes defined earlier, PCV2b (n = 19) and PCV2a
(n = 4).
According to the nomenclature previously established
[24] and supported by high confidence values, the ORF2
sequences from four Colombian PCV2a, were grouped
with those described as the PCV2 emergent variants as-
sociated with severe porcine circovirosis reported in
Canada (1998, 2007, 2012), USA (1998, 2004), China
(2001), and Korea (2008, 2009) in a defined cluster
within the genotype PCV2a (Figure 2). The remaining
PCV2 sequence was clustered within the genotype
PCV2b closely related to published sequences from
Canada (2007, 2012), USA (2007 - 2010), as well as
European, Asian, Caribbean and South American strains.
Sequence analysis and comparison of Colombian
PCV2b sequences with strains reported from South
America showed a very high level of homology. Identity
of 98.1% -99.8% at the nucleotide level and 94.4% -
97.8% at the amino acid level was found when compared
with six of the Brazilian strains included in this study
(accession numbers DQ861896, DQ861899, DQ861902,
EU057185, DQ923524 and EU755378). The comparison
with Argentinean strains (EU980087, EU980092 and
EU980093) revealed an identity ranging from 99% to
99.8% and 98.7% to 100% at the nucleotide and amino
acid level, respectively. At the same time, Colombian
PCV2b strains showed a high nucleotide (98.4%-99.7%)
and amino acid (94.4 %-97.8%) identity with three of the
Uruguayan strains included in this study (JN644769,
JN644770 and JN644771). By contrast, the comparison
with two Chilean strains revealed identity ranging from
92% to 95.8% at the nucleotide and 90.5% to 95.2% at
the amino acid level.
Discussion
PVC2 was detected in Colombian pigs associated with a
wide variety of clinical conditions as described previ-
ously [22,23]. In this study, the presence of PCV2 was
demonstrated by PCR in 22.4% of the serum and 83.6%
of the tissue samples examined. The identification of
PCV2 not only in cases associated with PMWS but also
in healthy pigs, suggests that various risk factors may
contribute to the exacerbation of PCV2 infection and
the development of associated lesions. An epidemio-
logical survey of PCVAD conducted between November
2008 and December 2009 in Colombia identified some
factors associated with high mortality rates in the three
major swine rearing areas in the country [22,23]. Herds
that did not have good management practice, presence
of poliserositis in weaned pig and low feed intake re-
sulted in a major risk of increased mortality. In that
study it was found that vaccination against PCV2, autho-
rized since 2008, represented a high effective
Table 3 Origin of 23 Colombian PCV2 ORF2 sequences examined in this study
Year of the colection PCV2 strain ID/original name Geographic origin Farm No. Designation clinical
condition
Sample origin Genotype
2002 CO6602 Valle 7 Non Wasting serum PCV-2b
2005 CO0505 Cundinamarca 2 non wasting serum PCV-2a
2006 CO1106 Cundinamarca 2 Wasting lymphoid node PCV-2b
2006 CO2906 Valle 7 Wasting lymphoid node PCV-2b
2006 CO3006 Valle 18 Wasting lymphoid node PCV-2b
2006 CO5106 Valle 10 Wasting lymphoid node PCV-2b
2007 CO1007 Cundinamarca 6 Wasting lymphoid node PCV-2b
2007 CO1407 Antioquia 13 Wasting lymphoid node PCV-2b
2009 C02239 Antioquia 22 Wasting lymphoid node PCV-2b
2009 CO2909 Valle 8 non wasting serum PCV-2b
2009 CO3009 Valle 21 non wasting serum PCV-2a
2009 CO3739 Valle 37 Wasting lymphoid node PCV-2b
2009 CO4309 Valle 8 Wasting lymphoid node PCV-2b
2009 CO4409 Antioquia 12 non wasting serum PCV-2b
2009 CO4909 Cundinamarca 1 Wasting lymphoid node PCV-2b
2009 CO5209 Antioquia 29 Wasting lymphoid node PCV-2b
2009 CO5709 Antioquia 26 Wasting lymphoid node PCV-2b
2009 CO7709 Antioquia 5 Wasting lymphoid node PCV-2b
2009 CO7909 Antioquia 28 Wasting lymphoid node PCV-2b
2009 CO9009 Valle 18 Wasting lymphoid node PCV-2a
2009 CO9109 Antioquia 29 non wasting serum PCV-2b
2009 CO9409 Valle 18 Wasting lymphoid node PCV-2a
2009 CO9809 Risaralda 20 non wasting serum PCV-2b
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even though PCV2 infection itself wasn’t considered a
risk factor for PCVAD development. It remains unclear
which factors contributed to maintain a subclinical
PCV2 infection in Colombian swine herds and thus it
needs to be further investigated.
Unfortunately, samples collected before 2002 were not
available at the time of the study, but it is reasonable to
assume that PCV2 was already present in the Colombian
pig population prior to this time frame. The earliest con-
firmed detection of PCV2 worldwide was in 1962
in Germany [25], before that, the virus was probably
causing subclinical infections or remained unknown for
many decades before the description of PCVAD as a
disease complex. An alternative to gain access to the
knowledge of the PCV2 infection is the use of archived
material, it is how in the UK investigations in archived
formalin-fixed material established PCV2 detection
using TaqMan1-PCR and immunohistochemistry in
material originated from the 1970s [26]. The earliest
PCV2 infection in Swiss archived material was found in
1986 by using immunohistochemistry, resulting in therecognition of the earliest histological lesions typical for
PCV2-associated systemic infection [27]. Similarly, a
study from Spain revealed the presence of PCV2 in ar-
chived material from 1985 onwards, and the occurrence
of typical PCV2-associated systemic infection lesions as
early as 1986 [28]. A retrospective study of PCV2 infec-
tion in Japan reported seven cases in 1989 [29]. Also, the
earliest PCV2 infection in Thailand was reported in
1993 by using Nested PCR from formalin fixed tissues of
PCV2-associated systemic infection affected pigs [30].
When considering Colombia, the data presented here
showed an increase in the incidence of PCV2b infection
between 2006-2007, in that period PCVAD was epizootic
and caused problems in numerous farms in several prov-
inces [22]. During that time, PCV2 positive samples by
immunohistochemistry were collected from pigs show-
ing characteristic lesions of PCV2-associated systemic
infection and some of them were later studied by PCR.
As mentioned earlier, 50 cases were collected from pigs
with wasting problems during a time period between
2009 -2010. Forty of these samples were PCR positive
and PCV2 DNA was identified in the 25.2% of the serum
Figure 3 Alignment of amino acids predicted from the ORF2 nucleotide sequences of the 23 Colombian PCV2 sequences during
2002-2010. Amino acid changes are located between amino acid positions 57-89, 121-134 and 190-210 (highlighted in red lines) comparison.
PCV1 isolate FJ475129 was included as outgroup.
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well known that detection of PCV2 alone, without the
three criteria for diagnostic of PCVAD, does not indicate
PCVAD but merely PCV2 infection [3]. However, there
was no evidence that could relate the PCV2 strain
groups and pathogenic PCV2 isolates from PCV2-
associated systemic infection cases and besides that itcannot be concluded that PCV2 isolates from healthy
pigs are non-pathogenic.
This study characterized and reconstructed phylogenetic
analysis of 23 ORF2 of PCV2 strains obtained from pigs
with PCV2-associated systemic infection and healthy pigs
during 2002 -2010. Molecular characterization of the iso-
lates was based on the analysis of cap gene. This region is
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phylogenetic marker for PCV2 strains since it is possible
to reconstruct the same tree as with the whole viral
genome [11]. Porcine circovirus type 2 (PCV2) is divided
into two major genotypes based on sequencing analysis.
Recently, both genotypes were proposed and referred to
as PCV2a and PCV2b [31].
The alignment of the amino acid sequences of the
ORF2 PCV2 capsid protein performed in the present
study has identified three major regions of amino acid
heterogeneity located at amino acid positions 57 -89,
121 – 134 and 190- 210 within heterogenic regions
(Figure 3) similar to previous reports [24,32]. It is inter-
esting to note that two of these regions (57-89 and 121-
134) correspond with two dominant immunoreactive
areas (65-87 and 113-139) as identified by Pepscan ana-
lysis [32]. These immunodominant regions of the capsid
protein of PCV2 exposed to selective immune pressure
could represent potential candidate regions involved in
the emergence of PCV2 variants. However, no repeatable
or characteristic amino acid motifs for these two regions
of the capsid protein of PCV2 could be associated with
strains identified from pigs with PCV2-associated sys-
temic infection or healthy pigs. Whether the anti-PCV2
antiserum generated from Colombian PCV2 strains
could recognize the same epitopes in strains from other
countries is not yet known but the results presented
here contribute to the knowledge of the variability of the
immunoreactive regions among PCV2 strains.
In terms of PCV2 genotype and its dynamics over time,
there was not a relationship between the genotype of
PCV2 and year of detection. Among the 23 Colombian
PCV2 strains in this study, the strain CO6602 collected in
2002 belonged to the genotype PCV2b, whereas in the
period from 2002 to 2010, in spite of being genotype 2b
more prevalent, the isolates were a mix of genotypes
PCV2a and PCV2b. The results presented here suggest
that PCV2b has become the main genotype acting in
Colombia over time. Previous studies revealed that both
genotypes were associated with PCVAD-affected and
non-affected herds [24,33-35]. Nevertheless, PCV2b is
currently prevailing in naturally occurring infections
worldwide [36], a similar situation could be occurring in
Colombian pig populations.
Furthermore, several recent publications have reported
a shift from the genotype PCV2a to PCV2b which might
be related to the occurrence of PCVAD outbreaks in
Canada [37], Sweden [38], Switzerland [35] and Spain
[39], indicating that PCV2b may be more virulent than
PCV2a. However, in Colombia PCV2b has been present
since 2002 in healthy animals and then it was associated
to the PCVAD epizootic occurrence in farms of several
regions of the country in the period 2006 – 2009. Never-
theless, in farm 2 a shift from PCV2a (2005) to PCV2b(2006) was found and, in farm 18 the variation was from
PCV2b (2006) to PCV2a (2009). In addition, the PCV2b
strains CO6602 and CO2906 collected in the same farm
in the years 2002 and 2006 respectively showed less than
1.3% differences in the amino acid sequence of ORF2. It
is well known that Colombia keeps a wide commercial ex-
change with North American countries, which includes
the import of live animals and semen, so it is not surpris-
ing that the strains analyzed in this work were found to be
closely related to Canadian and American strains isolated
between 2004 - 2010, sharing 74,7% - 100% identity at the
amino acid level. This coincides with findings in some
countries, where the presence of PCV2 has been linked to
imported pigs [40] and the movement of asymptomatic
PCV2- infected pigs that occurs as a result of the swine
trading which has been suggested to be responsible for the
rapid spread of PCV2 around the globe. Unfortunately,
there is a lack of information regarding the origin of
breeding animals in the herds which limits the capacity to
shed light over the potential source of infection and why it
is not possible to determine the exact year of introduction
of PCV2 in Colombian swine farms.
Conclusions
In Colombia, through the results presented here, it has
been demonstrated that PCV-2 is associated with PCVAD.
In this study, 23 ORF2 strains of PCV-2 were obtained
from animals with confirmed diagnosis of systemic and
subclinical infection originated from different farms in a
time frame from 2002 to 2010. Although in South America
data regarding molecular characterization of PCV2 strains
is still scarce, based on genotyping studies it has been con-
cluded that PCV2b is the predominant circulating geno-
type in the region. However in Colombia there was a
mixture of both genotypes during the epizootic, but re-
cently PCV2b became more common in cases of PCVAD.
This finding contributes to the understanding of the mo-
lecular epidemiology of PCV2 in Latin-American countries
and may also help to establish the bases necessary to study
the emergence of new viral variants in this region.
Methods
Samples
This study analyzed three different groups of samples,
each one from a different time frame. The first group cor-
responded to a retrospective study that included a total of
110 blood serum samples belonging to the bank sera of
the Instituto Colombiano Agropecuario (ICA) collected
during 2002 - 2005 as part of the national swine serologic
monitoring program which focused on farms with 50 or
more sows. Serum samples were from nursery/grower pigs
(6-12 weeks of age) from 22 previously reported seroposi-
tive farms and they were mostly from animals with un-
known or healthy clinical status [22]. The second group of
Table 4 Accession numbers and geographic origin of the ORF2 sequences included in the phylogenetic analysis
GenBank accession PCV2 strain ID/original Country origin Genotype Genotype references
AB072302 No. 26 Japan PCV-2a Imai et al. (2001)
AF055391 nd USA PCV-2a Meehan et al. (1998)
AF055392 nd Canada PCV-2a Meehan et al. (1998)
AF109399 2-E Canada PCV-2a Hamel et al. (2000)
AF154679 nd Taiwan PCV2-2a / 2B Kuo et al. (1999)
AF117753 2-D Canada PCV-2a Hamel et al. (2000)
AF201307 GER3 Germany PCV-2a / 2C Mankertz et al. (2000)
AF201309 SPA2 Spain PCV-2a Mankertz et al. (2000)
AF364094 nd Taiwan PCV-2a Wang et al. (2001)
AF381175 BF China PCV-2a Lu et al. (2001)
AY180397 Pingtung-5 China PCV-2a Liao et al. (2002)
AY256459 336 Hungary PCV2-2a 2C Dan et al. (2003)
AY321982 Fh14 France PCV-2b de Boisseson et al. (2004)
AY321983 Fh20 France PCV-2b de Boisseson et al. (2004)
AY321984 Fd3 France PCV-2b de Boisseson et al. (2004)
AY322001 Fh21 France PCV-2b de Boisseson et al. (2004)
AY484407 NL_Control_1 Netherlands PCV-2b Grierson et al. (2004)
AY484412 NL_Control_6 United Kingdom PCV-2b Grierson et al. (2004)
AY484415 NL_PMWS_3 United Kingdom PCV-2b Grierson et al. (2004)
AY556477 HuNan China PCV2- 2b 1C Zhixin et al. (2004)
AY678532 ZS0401 China PCV-2b Zhou et al. (2004)
AY682997 ZC China PCV-2b Wang et al. (2004)
AY691169 QZ0401 China PCV-2b Zhou et al. (2004)
AY699793 nd USA PCV2-2a 2E Fenaux et al. (2004)
AY847748 BJW Singapore PCV2-2b 1B Liu et al. (2005)
AY754017 Aust 6 Australia PCV2-2a 2A Muhling et al. (2005)
DQ151643 GS China PCV-2b Ma et al. (2005)
DQ220728 FMV05-6317 Canada PCV-2b Tremblay et al. (2005)
DQ220734 FMV05-7389 Canada PCV-2b Tremblay et al. (2005)
DQ220736 FMV05-7537 Canada PCV-2b Tremblay et al. (2005)
DQ220739 FMV05-6302 Canada PCV-2b Tremblay et al. (2005)
DQ233257 ROM Romania PCV-2b Cadar et al. (2007)
DQ629115 n32eu USA PCV-2b Cheung et al. (2007)
DQ629117 k52 USA PCV-2b Cheung et al. (2007)
DQ861896 am22 Brazil PCV-2b Castro et al. (2006)
DQ861899 am9 Brazil PCV-2b Castro et al. (2006)
DQ861902 am21 Brazil PCV-2b 1A Castro et al. (2006)
DQ870484 hk102 USA PCV-2a Cheung et al. (2007)
DQ923524 15/23R Brazil PCV-2b Dezen et al. (2010)
EF524517 GS04 China PCV-2d Wang et al. (2009)
EF524526 LN05 China PCV-2e Wang et al. (2009)
EF524533 GX0602 China PCV-2e Wang et al. (2009)
EF524539 TJ06 China PCV-2d Wang et al. (2009)
EU057185 P0404c/03 Brazil PCV-2b Esteves et al. (2007)
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Table 4 Accession numbers and geographic origin of the ORF2 sequences included in the phylogenetic analysis
(Continued)
EU148503 DK1980PMWSfree Denmark PCV-2c Dupont et al. (2008)
EU148505 DK1990PMWSfree Denmark PCV-2c Dupont et al. (2008)
EU186062 Chile C Chile PCV-2b Bucarey et al. (2007)
EF394775 05-22779 Canada PCV2 –2a 2E Tremblay et al. (2007)
EU519223 Chile-I Chile PCV-2b Bucarey et al. (2007)
EU747125 PCU1 Korea PCV-2a Vijayachandran et al. (2008)
EU755378 BRA9 Brazil PCV-2b Chiarelli-Neto et al. (2009)
EU980087 isolate 5 Argentina PCV-2b Pereda et al. (2008)
EU980092 isolate 11 Argentina PCV-2b Pereda et al. (2008)
EU980093 isolate 11 Argentina PCV-2b Pereda et al. (2008)
FJ233907 SoPCV2b Canada PCV-2b Chaiyakul et al. (2008)
FJ475129 BJ-1 China PCV1 Zhou et al. (2008)
FJ905463 C7155 Korea PCV-2b Kim et al. (2009)
FJ905471 C7189 Korea PCV-2a Kim et al. (2009)
FN398024 Villa Clara V2 Cuba PCV-2b Pérez et al. (2010)
FN398025 Villa Clara V4 Cuba PCV-2b Pérez et al. (2010)
FN398026 Pinar del Rio Cuba PCV-2b Pérez et al. (2010)
GQ404852 MN614 USA PCV-2b Li et al. (2010)
GU049341 Sp-10-7-54-13 Spain PCV-2b Fort et al. (2010)
GU049342 Sp-10-7-54-13 Spain PCV-2b Fort et al. (2010)
JN644769 SeUy1 Uruguay PCV-2b Ramos et al. (2010)
JN644770 SeUy2 Uruguay PCV-2b Ramos et al. (2010)
JN644771 SeUy3 Uruguay PCV-2b Ramos et al. (2010)
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between July 2006 and May 2007 from pigs with historical
records of PCV2-associated systemic infection (by immu-
nohistochemistry assays) from eleven different herds of
four Colombian geographic regions (Table 1).
Additionally, a third group of serum and tissue sam-
ples collected between January 2009 and February 2010
were also examined (Table 2). Five pigs per farm from
the 27 farms evaluated were used for serum collection.
The criteria for serum selection included the age (be-
tween 8 and 15 weeks), weight (under 60 kg) and no
clinical evidence of PCVAD in the animals. A total
of 50 pigs, between 6 to 16 weeks old, with wasting
problems after weaning were investigated in 18 of
these farms. Field veterinarians selected 1 - 5 pigs from
each farm based on loss of body condition, with the
additional clinical signs of diarrhea, skin pallor, and/or
respiratory disorders. Clinical samples (popliteal and in-
guinal lymph nodes, tonsil, spleen and kidney) of the
affected euthanized animals were collected. The samples
were kept at -70°C until performing DNA extraction and
PCR analysis.DNA extraction and PCV2 DNA amplification
The DNA was extracted from 200μl of serum or 20 mg of
organ tissue homogenate using a commercial kit (QIAamp
DNA Mini Kit, Qiagen, USA) according to the manufac-
turer’s recommendations. To avoid cross contamination,
samples were processed individually and stored at -20°C.
Conventional PCR for PCV-2 was performed using
primers previously described [41] which amplified a 657
base pair (bp) fragment. The forward primer (5′-GCC
AGTTCGTCACCCTTTC-3′) was located between gen-
omic positions 940 and 958 (found in PCV2 ORF1). The
reverse primer (5′-CTCCCGCACCTTCGGATAT-3′)
was located between positions 1578 and 1596 (found in
PCV2 ORF2). The optimized PCR reaction mixture con-
tained 200 nM dNTPs, 1.5 mM MgCl, 1× PCR buffer,
500 nM of each primer and 0.05U of Taq polymerase
(Promega M8298) in a 25 μl final volume.
The reactions were run in a thermocycler Bio Rad
ALS-1296 (Bio-rad Laboratories, Inc USA) under the
following conditions: one cycle at 94°C for 5 min,
followed by 35 cycles of 94°C during 30 s, primer an-
nealing 64°C for 1 min, initial extension at 72°C for 30 s,
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product was visualized by standard gel electrophoresis of
10 μl of the final reaction mixture on a 1.5% agarose gel
(Sigma A-9539) in TBE Buffer 10× (Invitrogen 15581-
044). Amplified DNA fragments of specific size were ob-
served by ultraviolet fluorescence after staining with EZ
Vision™ Three (Amresco N-313, USA). The length was
verified by a 100 bp DNA ladder (Invitrogen 15628-019).
Control DNA from a PCV2 strain (Genbank accession
number JF290418) was included in each reaction.
PCR amplification of ORF2 gene
One set of specific PCV2 primers, based on PCV2 gen-
ome from the strain ZhuJi2003 (AY579893) published in
the Gen Bank was designed to amplify the complete
ORF2 PCV2 sequence. A full-length ORF2 gene of
PCV2 was amplified by PCR with forward primer
(capFw 5′CCGTTGGAATGGTACTCCTC 3′) located
between genomic positions 825 and 844 (found in PCV2
ORF1). The reverse primer (cap Rw 5′ ACAGCGC
ACTTCTTTCGTTT3′) was located between positions
1760 - 1741 (found in PCV2 ORF2). PCV2 specific
primers amplified a 935 bp DNA fragment. The opti-
mized PCR reaction mixture contained 200 nM dNTPs,
1.5 mM MgCl, 1× PCR buffer, 600nM of each primer
and 0.05U Taq polymerase (Promega M8298). Reaction
conditions were as follows: initial denaturation at 94°C
for 5 min, followed by 35 cycles of 95°C during 45 s,
primer annealing 57°C for 45 s, initial extension at 72°
for 45 s, and a final extension of 72°C for 12 min.
The specificity of the primers was tested by adding
extracted nucleic acids from several viral and bacterial
swine pathogens such as: Actinobacillus pleuropneumo-
niae, (ATCC 27088), Mycoplasma hyopneumoniae (field
strain), Haemophilus parasuis (ATCC 19417), Streptococcus
suis (ATCC 700794), swine influenza virus H1N1 (A/SW/
Iowa/H1N1 NVSL 003 IDV 9501), porcine reproductive
and respiratory syndrome virus (NVSL 130 PDV 9801),
Aujeszky’s disease virus (Shope strain NVSL 070 -
PDV), porcine parvovirus (Mengeling strain NVSL 080-
PDV9501) and porcine circovirus type 1. Control DNA
from PCV1 was obtained from the supernatant of the
PK15 cell line, which is persistently infected with this
virus (ATCC CCL-33). The sensitivity of the PCV2 PCR
was estimated through the evaluation of serial DNA
dilutions extracted from the PCV2 positive control.
The amplified products were run in a 1.5% agarose gel
and visualized by staining with EZ VisionTM (Amresco
N -313, USA).
Viral sequences and phylogenetic analysis
DNA fragments of the calculated sizes were excised and
recovered from the agarose gel using spin columns as
described by the manufacturer (QIAquick Gel ExtractionKit, Qiagen 2876, USA). The purified PCR products
were used as templates in cycle sequencing reactions
primed with the PCV2 primers (capFw, capRw) and se-
quenced in both directions by Macrogen Sequencing
Service, USA. Sequence alignment was performed using
ClustalW software; genotype studies were performed
by analyzing ORF2 compared to published sequences
corresponding to different genotypes. The degree of iden-
tity among sequences at the nucleotide and amino acid
levels was determined using BioEdit package v.7.0.9 [42].
The phylogenetic tree was constructed by neighbor-
joining method with the Kimura two-parameter as the
model of nucleotide substitution using MEGA v.5.0 soft-
ware [43]. Confidence in the NJ tree was estimated by
1000 bootstrap replicates.
The sequencing of ORF2 presented greater difficulties
with the electropherograms, with lower quality peaks.
Only 23 were considered of good quality, with a defini-
tive interpretation of the base sequence. The phylogen-
etic tree was constructed for ORF2 by comparing
positive samples from various regions of Colombia as
well as 68 sequences from the GenBank database, repre-
sentative of all PCV2 genotypes described in North
America, South America, Europe, Cuba and Asian coun-
tries (Table 4). The tree was rooted with a PCV1 se-
quence (accession number FJ475129).
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